SCHEMBL2535885

SCHEMBL2535885

Cc1ccc(O)c(Cn2c(N)nc3ccc(CNc4cccc(OC(F)(F)F)c4)cc32)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.39
▸ NOS1 P29475 1/20 0.38
▸ P2RX3 P56373 4/20 0.38
▸ FLT1 P17948 4/20 0.36
▸ KDR P35968 3/20 0.36
▸ TGFBR1 P36897 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ KCNN3 Q9UGI6 1/20 0.35
▸ PPARA Q07869 1/20 0.34
▸ SCD O00767 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2537168 0.86 MAPT (0.46) NOS1SCDKDM4EMEN1ALDH1A1
SCHEMBL8284695 0.75 KDM4E (0.46) KDM4EALDH1A1GAAKMT2A
SCHEMBL12226831 0.75 SOS1 (0.35) SCDKDM4EMEN1ALDH1A1GAA
Acetic Acid SCHEMBL2541944 0.75 ACSS2 (0.37) KDRSCDKDM4EALDH1A1MAPT
SCHEMBL8241914 0.74 SOS1 (0.43) KDM4EALDH1A1GAAKMT2A
SCHEMBL8284674 0.73 SOS1 (0.42) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL12226826 0.73 KMT2A (0.34) SCDKDM4EMEN1ALDH1A1GAA
SCHEMBL2536267 0.73 MAPT (0.41) KDM4EMEN1ALDH1A1GAAMAPT
SCHEMBL8284672 0.72 SOS1 (0.41) KDM4EALDH1A1KMT2A
SCHEMBL23362168 0.71 CSF1R (0.45) P2RX3ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
EP-1697343-B1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARM LTD (IE) 2009-07-01 — — EP disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 PDE2A 4202/4885NOS1 1105/4885P2RX3 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback